Gastric cancer in the East and West: what should we learn from each other? Giovanni de Manzoni From the New Editors-in-Chief 21 November 2015 Pages: 1 - 1
The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines Toshirou NishidaJean-Yves BlayYoon-Koo Kang Invited Review Article Open access 15 August 2015 Pages: 3 - 14
Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference Gian Luca BaiocchiDomenico D’UgoGiovanni de Manzoni Special Report 04 July 2015 Pages: 15 - 20
Statistical monitoring of data quality and consistency in the Stomach Cancer Adjuvant Multi-institutional Trial Group Trial Catherine TimmermansErik DoffagneMarc Buyse Review Article 23 August 2015 Pages: 24 - 30
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer Giandomenico RovielloRoberto PetrioliFranco Roviello Review Article 02 September 2015 Pages: 31 - 41
Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer Jin Won KimKyung Han NamKeun-Wook Lee Original Article 26 November 2014 Pages: 42 - 52
Epithelial–mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells Paulina GrygielewiczBarbara DymekDaria Zdzalik Original Article Open access 19 November 2014 Pages: 53 - 62
Gene copy number gain of EGFR is a poor prognostic biomarker in gastric cancer: evaluation of 855 patients with bright-field dual in situ hybridization (DISH) method Eiji HigakiTakeshi KuwataAtsushi Ochiai Original Article 09 December 2014 Pages: 63 - 73
Interleukin-1B signalling leads to increased survival of gastric carcinoma cells through a CREB-C/EBPβ-associated mechanism Carlos ResendeGonçalo RegaloJosé C. Machado Original Article 05 March 2015 Pages: 74 - 84
RNAi-mediated gene silencing of ST6GalNAc I suppresses the metastatic potential in gastric cancer cells Fumito TamuraYasushi SatoJunji Kato Original Article 23 December 2014 Pages: 85 - 97
Methylation status of long interspersed element-1 in advanced gastric cancer and its prognostic implication Young Seok SongYounghoon KimGyeong Hoon Kang Original Article 22 January 2015 Pages: 98 - 106
Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer Mi-die XuLei DongXiang Du Original Article 28 January 2015 Pages: 107 - 115
Recurrent amplification of MYC and TNFRSF11B in 8q24 is associated with poor survival in patients with gastric cancer Xiaohong WangYiqiang LiuJia-fu Ji Original Article 25 January 2015 Pages: 116 - 127
The new modified ABCD method for gastric neoplasm screening Chan Hyuk ParkEun Hye KimYong Chan Lee Original Article 08 February 2015 Pages: 128 - 135
Carnoy’s solution increases the number of examined lymph nodes following gastrectomy for adenocarcinoma: a randomized trial Andre Roncon DiasMarina Alessandra PereiraUlysses Ribeiro Junior Original Article 20 November 2014 Pages: 136 - 142
Theoretical therapeutic impact of lymph node dissection on adenocarcinoma and squamous cell carcinoma of the esophagogastric junction Takaki YoshikawaHiroya TakeuchiYukinori Kurokawa Original Article 21 November 2014 Pages: 143 - 149
Prognostic factors in metastatic gastric cancer: results of a population-based, retrospective cohort study in Ontario Matthew DixonAlyson L. MaharNatalie G. Coburn Original Article 25 November 2014 Pages: 150 - 159
Biological behavior of the intramucosal Helicobacter pylori-negative undifferentiated-type early gastric cancer: comparison with Helicobacter pylori-positive early gastric cancer Yusuke HoriuchiJunko FujisakiHiroshi Takahashi Original Article 10 December 2014 Pages: 160 - 165
Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis Hai-Ning ChenZhu WangZong-Guang Zhou Original Article 22 January 2015 Pages: 166 - 175
HER2 testing in paired biopsy and excision specimens of gastric cancer: the reliability of the scoring system and the clinicopathological factors relevant to discordance Shih-Chiang HuangKwai-Fong NgTse-Ching Chen Original Article 17 December 2014 Pages: 176 - 182
Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients Nozomu FuseYasutoshi KubokiAtsushi Ohtsu Original Article 15 February 2015 Pages: 183 - 191
Incidence of lymphatic involvement in differentiated-type intramucosal gastric cancers as examined by endoscopic resection Yasuko FujitaMitsuo KishimotoAkio Yanagisawa Original Article 01 February 2015 Pages: 192 - 197
High rate of 5-year survival among patients with early gastric cancer undergoing curative endoscopic submucosal dissection Haruhisa SuzukiIchiro OdaYutaka Saito Original Article 24 January 2015 Pages: 198 - 205
Skip lymph node metastasis in gastric cancer: is it skipping or skipped? Yoon Young ChoiJi Yeong AnSung Hoon Noh Original Article 24 February 2015 Pages: 206 - 215
Preoperative locoregional staging of gastric cancer: is there a place for magnetic resonance imaging? Prospective comparison with EUS and multidetector computed tomography Francesco GigantiElena OrsenigoFrancesco De Cobelli Original Article 23 January 2015 Pages: 216 - 225
Risk factors for selection of patients at high risk of recurrence or death after complete surgical resection in stage I gastric cancer Ji Hyun ParkMin-Hee RyuYoon-Koo Kang Original Article 23 January 2015 Pages: 226 - 233
Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer Jinwan WangRuihua XuLin Shen Original article Open access 21 January 2015 Pages: 234 - 244
A phase II trial of concurrent 3D-CRT/IMRT and oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) in gastric cancer patients with R0 gastrectomy and D2 lymph node dissection Xin WangYali ShenFeng Xu Original Article 22 January 2015 Pages: 245 - 254
Adverse prognostic impact of perioperative allogeneic transfusion on patients with stage II/III gastric cancer Mitsuro KandaDaisuke KobayashiYasuhiro Kodera Original Article 07 January 2015 Pages: 255 - 263
The learning curve associated with laparoscopic total gastrectomy Do Hyun JungSang-Yong SonHyung-Ho Kim Original Article 07 December 2014 Pages: 264 - 272
Surgical management of duodenal stump fistula after elective gastrectomy for malignancy: an Italian retrospective multicenter study Luca CozzaglioMarco GiovenzanaVittorio Quagliuolo Original Article 10 December 2014 Pages: 273 - 279
Partially covered self-expandable metallic stent for postoperative benign strictures associated with laparoscopy-assisted gastrectomy Kwang Hyun ChungSang Hyub LeeYong-Tae Kim Original Article 12 December 2014 Pages: 280 - 286
Laparoscopic gastrectomy for remnant gastric cancer: a comprehensive review and case series Shigeru TsunodaHiroshi OkabeYoshiharu Sakai Original Article 13 December 2014 Pages: 287 - 292
C-reactive protein on postoperative day 3 as a predictor of infectious complications following gastric cancer resection Yuji ShishidoKazumasa FujitaniMitsugu Sekimoto Original Article 06 January 2015 Pages: 293 - 301
Assessment of postoperative quality of life following pylorus-preserving gastrectomy and Billroth-I distal gastrectomy in gastric cancer patients: results of the nationwide postgastrectomy syndrome assessment study Junya FujitaMasazumi TakahashiKoji Nakada Original Article 31 January 2015 Pages: 302 - 311
Long-term quality of life after surgery for adenocarcinoma of the esophagogastric junction: extended gastrectomy or transthoracic esophagectomy? Hans FuchsArnulf H. HölscherChristian A. Gutschow Original Article 28 January 2015 Pages: 312 - 317
Inconsistent conclusions on QoL outcomes from the same clinical trial Stefan LangeJan GaertnerVera Weingärtner Letter to the Editor 18 April 2015 Pages: 318 - 319
Reply to the Letter to the Editor Melanie KrippSalah-Eddin Al-BatranRalf-Dieter Hofheinz Letter to the Editor 20 August 2015 Pages: 320 - 321
